Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.85
Delayed Data
As of 4:03pm ET
 -1.11 / -2.65%
Today’s Change
37.20
Today|||52-Week Range
45.58
+6.08%
Year-to-Date
What Financial Modeling Says About Gilead Sciences
11:49am / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Alphabet, GlaxoSmithKline, T-Mobile, Northrop Grum...
Jul 24 / Zacks.com - Paid Partner Content
Glaxo (GSK) Beats Q2 Earnings, Misses Sales
9:50am / Zacks.com - Paid Partner Content
Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile
Jul 21 / Zacks.com - Paid Partner Content
GSK Stock Falls On Reduced Guidance
7:12am / TheStreet.com - Paid Partner Content
Emergent Inks Agreement to Acquire Anthrax Drug Raxibacumab
Jul 20 / Zacks.com - Paid Partner Content
Drug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK
Jul 25 / Zacks.com - Paid Partner Content
Asset Advisors Corp Buys Schwab International Equity, dorma+kaba Holding AG, ABB, Sel...
Jul 20 / GuruFocus News - Paid Partner Content
GlaxoSmithKline Names Former Walmart Exec as New CTO
Jul 25 / TheStreet.com - Paid Partner Content
What Lies in Store for Glaxo (GSK) this Earnings Season?
Jul 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close41.96
Today’s open41.41
Day’s range40.79 - 41.48
Volume4,652,333
Average volume (3 months)2,795,362
Market cap$103.2B
Dividend yield6.10%
Data as of 4:03pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+12.54%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+2.85%
P/E ratio59.9
Price/Sales2.52
Price/Book73.53

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+1.31+0.96%
BMYBristol-Myers Squibb+0.03+0.05%
ABBVAbbVie+0.07+0.10%
LLYEli Lilly and Co-0.35-0.43%
Data as of 4:02pm ET, 07/26/2017

Financials

Last reporting dateJuly 26, 2017
EPS forecast (this quarter)$0.68
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts